Walleye Trading Advisors »

Arcutis Biotherapeutics shares owned by Walleye Trading Advisors

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Walleye Trading Advisors from 13F filings

Historical chart of Walleye Trading Advisors investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Walleye Trading Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Walleye Trading Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.0M 324k 3.23
2022-03-31 $1.5M 76k 19.26
2021-12-31 $1.7M 83k 20.74

More positions owned by Walleye Trading Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Put Option (MSFT)
Apple Put Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon Put Option (AMZN)
Tesla Motors Put Option (TSLA)
Meta Platforms Cl A Call Option (META)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Advanced Micro Devices Put Option (AMD)
Alphabet Cap Stk Cl C Put Option (GOOG)
Select Sector Spdr Tr Financial Call Option (XLF)
Palo Alto Networks Call Option (PANW)

View all positions for Walleye Trading Advisors

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Frazier Life Sciences Management
Vanguard Group
Franklin Resources
Millennium Management
Opaleye Management
Jennifer Ranahan
Deutsche Bank Aktiengesellschaft
Tejara Capital
Two Sigma Investments
Goldman Sachs Group
Charles Schwab Investment Management
Federated Investors
AMI Asset Management Corporation
Walleye Trading Advisors

View all funds holding Arcutis Biotherapeutics